GURUFOCUS.COM » STOCK LIST » Healthcare » Medical Devices & Instruments » Straumann Holding AG (FRA:QS51) » Definitions » EV-to-EBIT

Straumann Holding AG (FRA:QS51) EV-to-EBIT : 63.41 (As of Apr. 29, 2024)


View and export this data going back to 2009. Start your Free Trial

What is Straumann Holding AG EV-to-EBIT?

EV-to-EBIT is calculated as Enterprise Value divided by its EBIT. As of today, Straumann Holding AG's Enterprise Value is €23,726 Mil. Straumann Holding AG's EBIT for the trailing twelve months (TTM) ended in Dec. 2023 was €374 Mil. Therefore, Straumann Holding AG's EV-to-EBIT for today is 63.41.

The historical rank and industry rank for Straumann Holding AG's EV-to-EBIT or its related term are showing as below:

FRA:QS51' s EV-to-EBIT Range Over the Past 10 Years
Min: 15.84   Med: 38.27   Max: 252.76
Current: 60.5

During the past 13 years, the highest EV-to-EBIT of Straumann Holding AG was 252.76. The lowest was 15.84. And the median was 38.27.

FRA:QS51's EV-to-EBIT is ranked worse than
86.39% of 463 companies
in the Medical Devices & Instruments industry
Industry Median: 19.98 vs FRA:QS51: 60.50

Joel Greenblatt calls the inversion of this ratio Earnings Yield (Joel Greenblatt) %. Straumann Holding AG's Enterprise Value for the quarter that ended in Dec. 2023 was €12,406 Mil. Straumann Holding AG's EBIT for the trailing twelve months (TTM) ended in Dec. 2023 was €374 Mil. Straumann Holding AG's Earnings Yield (Joel Greenblatt) % for the quarter that ended in Dec. 2023 was 3.02%.


Straumann Holding AG EV-to-EBIT Historical Data

The historical data trend for Straumann Holding AG's EV-to-EBIT can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Straumann Holding AG EV-to-EBIT Chart

Straumann Holding AG Annual Data
Trend Dec14 Dec15 Dec16 Dec17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23
EV-to-EBIT
Get a 7-Day Free Trial Premium Member Only Premium Member Only 39.88 127.28 62.01 32.65 59.41

Straumann Holding AG Semi-Annual Data
Jun14 Dec14 Jun15 Dec15 Jun16 Dec16 Jun17 Dec17 Jun18 Dec18 Jun19 Dec19 Jun20 Dec20 Jun21 Dec21 Jun22 Dec22 Jun23 Dec23
EV-to-EBIT Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 62.01 - 32.65 - 59.41

Competitive Comparison of Straumann Holding AG's EV-to-EBIT

For the Medical Instruments & Supplies subindustry, Straumann Holding AG's EV-to-EBIT, along with its competitors' market caps and EV-to-EBIT data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Straumann Holding AG's EV-to-EBIT Distribution in the Medical Devices & Instruments Industry

For the Medical Devices & Instruments industry and Healthcare sector, Straumann Holding AG's EV-to-EBIT distribution charts can be found below:

* The bar in red indicates where Straumann Holding AG's EV-to-EBIT falls into.



Straumann Holding AG EV-to-EBIT Calculation

Straumann Holding AG's EV-to-EBIT for today is calculated as:

EV-to-EBIT=Enterprise Value (Today)/EBIT (TTM)
=23725.965/374.188
=63.41

Straumann Holding AG's current Enterprise Value is €23,726 Mil.
For company reported semi-annually, GuruFocus uses latest annual data as the TTM data. Straumann Holding AG's EBIT for the trailing twelve months (TTM) ended in Dec. 2023 was €374 Mil.

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.


Straumann Holding AG  (FRA:QS51) EV-to-EBIT Explanation

This is a more accurate valuation of companies' operation because it considers the debt and cash on its balance sheet, and non-operating items such as interest payment, tax, and one-time items are not included in the Operating Income.

Joel Greenblatt calls the inversion of this ratio Earnings Yield (Joel Greenblatt) %.

Straumann Holding AG's Earnings Yield (Joel Greenblatt) % for the quarter that ended in Dec. 2023 is calculated as:

Earnings Yield (Joel Greenblatt) % (Q: Dec. 2023 ) =EBIT / Enterprise Value (Q: Dec. 2023 )
=374.188/12405.9834
=3.02 %

Straumann Holding AG's Enterprise Value for the quarter that ended in Dec. 2023 was €12,406 Mil.
For company reported semi-annually, GuruFocus uses latest annual data as the TTM data. Straumann Holding AG's EBIT for the trailing twelve months (TTM) ended in Dec. 2023 was €374 Mil.

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.


Straumann Holding AG EV-to-EBIT Related Terms

Thank you for viewing the detailed overview of Straumann Holding AG's EV-to-EBIT provided by GuruFocus.com. Please click on the following links to see related term pages.


Straumann Holding AG (FRA:QS51) Business Description

Address
Peter Merian-Weg 12, Basel, CHE, 4002
Straumann is a global leader in tooth replacement and orthodontics solutions. Its line of products includes dental implants, abutments, clear aligners, biomaterials, and computer-aided design/computer-aided manufacturing equipment. The company's core products are dental implants, and it holds roughly 30% of the global implant dentistry market, which is estimated to be worth roughly CHF 5.4 billion. Originally a pure premium implant player, Straumann entered the value market in 2012 with its acquisition of Neodent. Straumann now accounts for almost half of the global premium market and around 15% of the value market. While its premium product catalog is marketed under Straumann, its value brands include Neodent, Anthogyr, and Medentika as well as other local and regional brands.

Straumann Holding AG (FRA:QS51) Headlines

No Headlines